Business Description
SyntekaBio Inc
ISIN : KR7226330009
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | -0.64 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.13 | |||||
Beneish M-Score | 36.26 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -42.8 | |||||
3-Year EBITDA Growth Rate | -17 | |||||
3-Year EPS without NRI Growth Rate | -19.8 | |||||
3-Year FCF Growth Rate | -42.8 | |||||
3-Year Book Growth Rate | -13 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.9 | |||||
9-Day RSI | 57.63 | |||||
14-Day RSI | 57.91 | |||||
6-1 Month Momentum % | -50.99 | |||||
12-1 Month Momentum % | -60.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 1 | |||||
Days Sales Outstanding | 20.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.5 | |||||
Shareholder Yield % | 4.93 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -7818.61 | |||||
Net Margin % | -13387.52 | |||||
FCF Margin % | -18578.94 | |||||
ROE % | -47.7 | |||||
ROA % | -29.4 | |||||
ROIC % | -20.55 | |||||
ROC (Joel Greenblatt) % | -42.53 | |||||
ROCE % | -32.46 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 868.65 | |||||
PB Ratio | 3.66 | |||||
Price-to-Tangible-Book | 3.43 | |||||
EV-to-EBIT | -6.84 | |||||
EV-to-EBITDA | -7.89 | |||||
EV-to-Revenue | 710.48 | |||||
EV-to-FCF | -4.04 | |||||
Earnings Yield (Greenblatt) % | -14.63 | |||||
FCF Yield % | -21.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
SyntekaBio Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 122.334 | ||
EPS (TTM) (â‚©) | -1247.132 | ||
Beta | 1.44 | ||
Volatility % | 47.16 | ||
14-Day RSI | 57.91 | ||
14-Day ATR (â‚©) | 554.214626 | ||
20-Day SMA (â‚©) | 5908.5 | ||
12-1 Month Momentum % | -60.98 | ||
52-Week Range (â‚©) | 4195 - 14880 | ||
Shares Outstanding (Mil) | 15.26 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SyntekaBio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SyntekaBio Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
SyntekaBio Inc Frequently Asked Questions
What is SyntekaBio Inc(XKRX:226330)'s stock price today?
When is next earnings date of SyntekaBio Inc(XKRX:226330)?
Does SyntekaBio Inc(XKRX:226330) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |